Skip to main content
Top
Published in: Journal of Neurology 8/2006

01-08-2006

Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging

Authors: Sanjay Kalra, Peter Tai, Angela Genge, Douglas L. Arnold

Published in: Journal of Neurology | Issue 8/2006

Login to get access

Abstract

Riluzole prolongs survival in amyotrophic lateral sclerosis. The temporal and spatial profile of its effect on the brain is unknown. We used proton magnetic resonance spectroscopic imaging to evaluate the neuronal response to 1 day of riluzole treatment in motor and non-motor regions of the brain. In 10 patients the N-acetylaspartate/total creatine (NAA/Cr) ratio increased in the precentral gyrus and supplementary motor area, but not in the post-central gyrus or parietal lobe. Improvement in cortical neuronal metabolic function in the motor cortex occurs early with riluzole treatment.
Literature
1.
go back to reference Cendes F, Andermann F, Dubeau F, Matthews PM, Arnold DL (1997) Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging. Neurology 49:1525–1533PubMed Cendes F, Andermann F, Dubeau F, Matthews PM, Arnold DL (1997) Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging. Neurology 49:1525–1533PubMed
2.
go back to reference Dautry C, Vaufrey F, Brouillet E, Bizat N, Henry PG, Conde F, Bloch G, Hantraye P (2000) Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3- nitropropionic acid. J Cereb Blood Flow Metab 20:789–799PubMedCrossRef Dautry C, Vaufrey F, Brouillet E, Bizat N, Henry PG, Conde F, Bloch G, Hantraye P (2000) Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3- nitropropionic acid. J Cereb Blood Flow Metab 20:789–799PubMedCrossRef
3.
go back to reference De Stefano N, Matthews PM, Arnold DL (1995) Reversible decreases in N-acetylaspartate after acute brain injury. MRM (AUTHOR PLEASE GIVE INDEX MEDICUS NAME OF JOURNAL)34:721–727 De Stefano N, Matthews PM, Arnold DL (1995) Reversible decreases in N-acetylaspartate after acute brain injury. MRM (AUTHOR PLEASE GIVE INDEX MEDICUS NAME OF JOURNAL)34:721–727
4.
go back to reference Ernst T (2005) Quantification and analysis in MR spectroscopy In: Gillard JH, Waldman AD, Barker PB (eds) Clinical MR Neuroimaging. Diffusion, Perfusion and Spectroscopy Cambridge University Press Cambridge pp. 27–37 Ernst T (2005) Quantification and analysis in MR spectroscopy In: Gillard JH, Waldman AD, Barker PB (eds) Clinical MR Neuroimaging. Diffusion, Perfusion and Spectroscopy Cambridge University Press Cambridge pp. 27–37
5.
go back to reference Kalra S, Cashman NR, Genge A, Arnold DL (1998) Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 9:1757–1761PubMed Kalra S, Cashman NR, Genge A, Arnold DL (1998) Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 9:1757–1761PubMed
6.
go back to reference Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V (1996) Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 347:1425–1431PubMed Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V (1996) Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 347:1425–1431PubMed
7.
go back to reference Martin JE, Swash M (1995) The pathology of motor neuron disease In: Leigh PN, Swash M (eds) Motor Neuron Disease. Biology and Management Springer-Verlag London pp. 93–118 Martin JE, Swash M (1995) The pathology of motor neuron disease In: Leigh PN, Swash M (eds) Motor Neuron Disease. Biology and Management Springer-Verlag London pp. 93–118
8.
go back to reference Moreno A, Ross BD, Bluml S (2001) Direct determination of the N-acetyl-L-aspartate synthesis rate in the human brain by (13)C MRS and [1-(13)C]glucose infusion. J Neurochem 77:347–350PubMedCrossRef Moreno A, Ross BD, Bluml S (2001) Direct determination of the N-acetyl-L-aspartate synthesis rate in the human brain by (13)C MRS and [1-(13)C]glucose infusion. J Neurochem 77:347–350PubMedCrossRef
9.
go back to reference Parent A (1996) Carpenter’s Human Neuroanatomy Williams and Wilkins Baltimore Parent A (1996) Carpenter’s Human Neuroanatomy Williams and Wilkins Baltimore
10.
go back to reference Pioro EP, Antel JP, Cashman NR, Arnold DL (1994) Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology 44:1933–1938PubMed Pioro EP, Antel JP, Cashman NR, Arnold DL (1994) Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology 44:1933–1938PubMed
11.
go back to reference Schinder AF, Olson EC, Spitzer NC, Montal M (1996) Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. Journal of Neuroscience 16:6125–6133PubMed Schinder AF, Olson EC, Spitzer NC, Montal M (1996) Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. Journal of Neuroscience 16:6125–6133PubMed
12.
go back to reference Stefan K, Kunesch E, Benecke R, Classen J (2001) Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis. Ann Neurol 49:536–539PubMedCrossRef Stefan K, Kunesch E, Benecke R, Classen J (2001) Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis. Ann Neurol 49:536–539PubMedCrossRef
13.
go back to reference Vion-Dury J, Nicoli F, Salvan AM, Confort-Gouny S, Dhiver C, Cozzone PJ (1995) Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy. Lancet 345:60–61PubMedCrossRef Vion-Dury J, Nicoli F, Salvan AM, Confort-Gouny S, Dhiver C, Cozzone PJ (1995) Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy. Lancet 345:60–61PubMedCrossRef
14.
go back to reference Zhu XH, Chen W (2001) Observed BOLD effects on cerebral metabolite resonances in human visual cortex during visual stimulation: a functional (1)H MRS study at 4 T Magn Reson. Med 46:841–847PubMedCrossRef Zhu XH, Chen W (2001) Observed BOLD effects on cerebral metabolite resonances in human visual cortex during visual stimulation: a functional (1)H MRS study at 4 T Magn Reson. Med 46:841–847PubMedCrossRef
Metadata
Title
Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging
Authors
Sanjay Kalra
Peter Tai
Angela Genge
Douglas L. Arnold
Publication date
01-08-2006
Publisher
Steinkopff-Verlag
Published in
Journal of Neurology / Issue 8/2006
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-006-0162-7

Other articles of this Issue 8/2006

Journal of Neurology 8/2006 Go to the issue